Nanosuspensions for Enhanced Oral Bioavailability

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".

Deadline for manuscript submissions: closed (20 May 2022) | Viewed by 382

Special Issue Editors


E-Mail Website
Guest Editor
College of Pharmacy, Duksung Women’s University, 33, Samyangro 144-gil, Dobong-gu, Seoul 01369, Republic of Korea
Interests: nano/microparticle technologies - supercritical fluid technology, spray drying, spray freeze drying, jet-milling, high-pressure homogenization; dry powder inhalation (DPI) - pulmonary/nasal; drug delivery systems - SMEDDS, SNEDDS, micelle, liposome, liquid crystal; sustained release injectable preparation - PLGA microspheres, multivesicular liposomes; process analytical technology (PAT)
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
College of Pharmacy, Pusan National University, 63 Busandaehak-ro, Geumjeong-gu, Busan 46241, Republic of Korea
Interests: sustained and controlled release formulation of drugs; quality by design; formulation and stabilization of emulsion, microemulsion and liposomes; solubilization techniques of poorly water-soluble drugs; polymorphism and cocrystal; coating and pelletization technology; targeted drug delivery system; microspheres and microcapsules; pharmacokinetics and bioequivalent study; drug stability; supercritical fluid technology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Many drug candidates in the new drug development stage are included in the biopharmaceutical classification system (BCS) class II or IV; these have poor water solubility, which usually leads to low bioavailability. However, the development of nanosuspension technology has changed the paradigm of the past, where water-insoluble drugs were discarded, and accelerated research to breathe life into BCS class II and IV drugs that were kept in warehouses. Typically, nanosuspension formulation can result in the enhanced dissolution rate of poorly water-soluble drugs, hence improving the rate and extent of drug absorption and optimizing the bioavailability.

 Several nanosuspension production technologies have been widely used to reduce drug particle size. The processes for nanosuspension are typically categorized into “top-down” and “bottom-up” methods. Top-down methods use mechanical comminution processes, including various dry/wet milling and high-pressure homogenization. In contrast, bottom-up methods are generally based on the particle precipitation processes such as spray drying, supercritical nanoparticle formation processes, and spray freeze drying. Moreover, novel techniques by combination of bottom-up and top-down were also introduced.

The aim of this Special Issue is to introduce recent developments and findings for all topics related to the nanosuspension. Thus, this Special Issue devotes mainly applied aspects, including application of novel bioactive materials to nanosuspension, the development of novel nanosuspension manufacturing technologies or formulations, the evaluation of biopharmaceutical performance for specialized administration routes, and physicochemical instability of nanosuspension and approaches to overcome it. Applicable bioactive materials are not limited to drugs, but may also include natural products with biological activity.

Prof. Dr. Heejun Park
Prof. Dr. Min-Soo Kim
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanosuspension
  • nanodispersion
  • nanocrystal
  • top-down
  • bottom-up
  • stability
  • solubility
  • dissolution
  • absorption
  • bioavailability

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop